Literature DB >> 20399185

The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.

Mark F Rosenberg1, Zsolt Bikadi, Janice Chan, Xiaoping Liu, Zhanglin Ni, Xiaokun Cai, Robert C Ford, Qingcheng Mao.   

Abstract

BCRP/ABCG2 mediates efflux of drugs and xenobiotics. BCRP was expressed in Pichia pastoris, purified to > 90% homogeneity, and subjected to two-dimensional (2D) crystallization. The 2D crystals showed a p12(1) symmetry and projection maps were determined at 5 A resolution by cryo-electron microscopy. Two crystal forms with and without mitoxantrone were observed with unit cell dimensions of a = 55.4 A, b = 81.4 A, gamma = 89.8 degrees , and a = 57.3 A, b = 88.0 A, gamma = 89.7 degrees , respectively. The projection map without mitoxantrone revealed an asymmetric structure with ring-shaped density features probably corresponding to a bundle of transmembrane alpha helices, and appeared more open and less symmetric than the map with mitroxantrone. The open and closed inward-facing forms of BCRP were generated by homology modeling, representing the substrate-free and substrate-bound conformations in the absence of nucleotide, respectively. These models are consistent with the experimentally observed conformational change upon substrate binding. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399185      PMCID: PMC2858361          DOI: 10.1016/j.str.2010.01.017

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  39 in total

1.  Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

2.  Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography.

Authors:  Anling Kuo; Carmen Domene; Louise N Johnson; Declan A Doyle; Catherine Vénien-Bryan
Journal:  Structure       Date:  2005-10       Impact factor: 5.006

3.  Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study.

Authors:  Yong-Fu Li; Orsolya Polgar; Masaki Okada; Lothar Esser; Susan E Bates; Di Xia
Journal:  J Mol Graph Model       Date:  2006-08-30       Impact factor: 2.518

4.  Atomic model of plant light-harvesting complex by electron crystallography.

Authors:  W Kühlbrandt; D N Wang; Y Fujiyoshi
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

5.  Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

Authors:  Orsolya Polgar; Csilla Ozvegy-Laczka; Robert W Robey; Kuniaki Morisaki; Masaki Okada; Akina Tamaki; Gabriella Koblos; N Barry Elkind; Yvona Ward; Michael Dean; Balazs Sarkadi; Susan E Bates
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

7.  Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Mark F Rosenberg; Alhaji Bukar Kamis; Luba A Aleksandrov; Robert C Ford; John R Riordan
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

Review 8.  ABCG2: a perspective.

Authors:  Robert W Robey; Kenneth K K To; Orsolya Polgar; Marius Dohse; Patricia Fetsch; Michael Dean; Susan E Bates
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

9.  Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding.

Authors:  Mark F Rosenberg; Alhaji Bukar Kamis; Richard Callaghan; Christopher F Higgins; Robert C Ford
Journal:  J Biol Chem       Date:  2002-12-25       Impact factor: 5.157

10.  Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  31 in total

1.  Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.

Authors:  Chenrui Li; Li Zhang; Limin Zhou; Siu Kwan Wo; Ge Lin; Zhong Zuo
Journal:  AAPS J       Date:  2011-12-14       Impact factor: 4.009

2.  Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study.

Authors:  Anna Jacobs; Dana Emmert; Svenja Wieschrath; Christine A Hrycyna; Michael Wiese
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

Review 3.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

4.  Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo.

Authors:  Kamlesh Sodani; Atish Patel; Nagaraju Anreddy; Satyakam Singh; Dong-Hua Yang; Rishil J Kathawala; Priyank Kumar; Tanaji T Talele; Zhe-Sheng Chen
Journal:  Biochem Pharmacol       Date:  2014-02-22       Impact factor: 5.858

Review 5.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

6.  Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.

Authors:  Zhanglin Ni; Zsolt Bikadi; Xiaokun Cai; Mark F Rosenberg; Qingcheng Mao
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

Review 7.  The ABCG family of membrane-associated transporters: you don't have to be big to be mighty.

Authors:  Ian D Kerr; Ameena J Haider; Ingrid C Gelissen
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 8.  Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2014-09-19       Impact factor: 4.009

9.  ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Authors:  De-Shen Wang; Atish Patel; Hong-May Sim; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Hui Zhang; Tanaji T Talele; Suresh V Ambudkar; Rui-Hua Xu; Zhe-Sheng Chen
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

10.  Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain.

Authors:  Guillermo Moreno-Sanz; Borja Barrera; Andrea Armirotti; Sine M Bertozzi; Rita Scarpelli; Tiziano Bandiera; Julio G Prieto; Andrea Duranti; Giorgio Tarzia; Gracia Merino; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2014-06-30       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.